Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

Clinical trial NCT03287167 · UNKNOWN

Trial details

NCT number: NCT03287167
Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Disease Drug Eluting Stent Percutaneous Coronary Intervention Dual Antiplatelet Therapy

Start date: 2019-06-01
Primary completion: 2021-07-01
Enrollment: 1720

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.